{"name":"Inventages Venture Capital Investment Inc.","permalink":"inventages-venture-capital-investment-inc","crunchbase_url":"http://www.crunchbase.com/financial-organization/inventages-venture-capital-investment-inc","homepage_url":"http://www.inventages.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"+41 22 960 77 00","description":"","email_address":"office.manager@inventages.com","number_of_employees":null,"founded_year":2000,"founded_month":null,"founded_day":null,"tag_list":"investment, middle-market, mature-companies, mezzanine, bridge-financing, pharmaceuticals, diagnostic","alias_list":"","created_at":"Tue Jun 23 20:01:53 UTC 2009","updated_at":"Tue Jun 23 21:14:09 UTC 2009","overview":"<p>Inventages Venture Capital Investment Inc is an investment arm of Nestle SA specializing in PIPES, seed, early, mid, and late venture investments. The firm seeks to invest in middle market and mature companies. It provides mezzanine and bridge financing. The firm seeks to invest in health care, life sciences, cosmeceuticals, pharmaceuticals, enabling technologies and services, and diagnostic and medical devices. Within the pharmaceutical sector, it typically invests in small molecules, proteins, antibodies, vaccines, phytopharmaceuticals, natural compounds, botanicals, antibiotics, and therapeutics. Within the diagnostic sector, it focuses on genetic materials, biomarkers, pathological markers, genetic profiles, protein profiles, pharmacogenomics, food and environmental safety, genetically modified organism detection and trading, medical monitoring, diagnostic and analytical tools, and quality control. Within enabling technologies and services it primarily invests in novel packaging, process and production technologies, supply chain management, innovative materials and resources, delivery systems for active compounds, encapsulation and prevention, food services, extraction and fractionation of biological materials, consumer relation management, green biotechnology, smell and taste modifying technologies, genomics, proteomics, metabolomics, screen and characterization technologies, chemical and biological engineering, and innovative preventive and therapeutic concepts. It also invests in companies involved in the prevention of medical foods, nutraceuticals, cosmoceuticals, nutrition, innovative food, functional food, dietary and food supplements, oral and skin care, immune modulation and stimulation, and health and disease management.</p>","image":{"available_sizes":[[[150,42],"assets/images/resized/0005/0396/50396v1-max-150x150.png"],[[208,59],"assets/images/resized/0005/0396/50396v1-max-250x250.png"],[[208,59],"assets/images/resized/0005/0396/50396v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"Route de Coppet 26A","address2":"","zip_code":"CH-1291","city":"","state_code":null,"country_code":"CHE","latitude":46.3180061,"longitude":6.1785338},{"description":"","address1":"Cable Beach Courts Unit #1","address2":"PO Box N-7532","zip_code":"","city":"Nassau","state_code":null,"country_code":"BHS","latitude":null,"longitude":null},{"description":"","address1":"Marlborough & Queens Street","address2":"PO Box N-3026 ","zip_code":"","city":"Nassau","state_code":null,"country_code":"BHS","latitude":27.04874,"longitude":-82.076523},{"description":"","address1":"Level 6, 2 Kitchener Street","address2":"PO Box 6466 Wellesley Street","zip_code":"","city":"Auckland","state_code":null,"country_code":"NZL","latitude":null,"longitude":null}],"relationships":[{"is_past":false,"title":"Director","person":{"first_name":"Geoffrey","last_name":"Hooper","permalink":"geoffrey-hooper","image":null}}],"investments":[{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/accera-raises-35m/2008-11-12","source_description":"Accera raises $35M","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":11,"funded_day":12,"company":{"name":"Accera","permalink":"accera","image":{"available_sizes":[[[150,55],"assets/images/resized/0005/0389/50389v1-max-150x150.png"],[[250,92],"assets/images/resized/0005/0389/50389v1-max-250x250.png"],[[251,93],"assets/images/resized/0005/0389/50389v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/opsona-therapeutics-ltd-series-b-46m/","source_description":"Opsona Therapeutics, Ltd.: Series B $4.6M","raised_amount":4600000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":16,"company":{"name":"Opsona","permalink":"opsona","image":{"available_sizes":[[[150,51],"assets/images/resized/0004/8845/48845v1-max-150x150.png"],[[219,75],"assets/images/resized/0004/8845/48845v1-max-250x250.png"],[[219,75],"assets/images/resized/0004/8845/48845v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://deals.venturebeat.com/2007/04/16/diobex-a-metabolic-disease-treatment-co-raises-24m/","source_description":"DiObex, a metabolic disease treatment co., raises $24M","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":4,"funded_day":16,"company":{"name":"DiObex","permalink":"diobex","image":{"available_sizes":[[[150,39],"assets/images/resized/0005/9950/59950v1-max-150x150.jpg"],[[163,43],"assets/images/resized/0005/9950/59950v1-max-250x250.jpg"],[[163,43],"assets/images/resized/0005/9950/59950v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.freshnews.com/news/211690/moobella-inc-closes-18-million-series-funding","source_description":"MOOBELLA, INC. CLOSES $18 MILLION IN SERIES A FUNDING","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":9,"funded_day":18,"company":{"name":"MooBella","permalink":"moobella","image":{"available_sizes":[[[150,65],"assets/images/resized/0006/0218/60218v1-max-150x150.jpg"],[[154,67],"assets/images/resized/0006/0218/60218v1-max-250x250.jpg"],[[154,67],"assets/images/resized/0006/0218/60218v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020100122e61p000dy&r=Rss&s=DJFVW","source_description":" Tanfield Gobbles $6.5M Growth Capital For Natural Foods","raised_amount":4000000,"raised_currency_code":"GBP","funded_year":2010,"funded_month":1,"funded_day":25,"company":{"name":"Tanfield Direct Ltd.","permalink":"tanfield-direct-ltd","image":{"available_sizes":[[[150,45],"assets/images/resized/0007/4518/74518v1-max-150x150.jpg"],[[250,75],"assets/images/resized/0007/4518/74518v1-max-250x250.jpg"],[[257,78],"assets/images/resized/0007/4518/74518v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://findarticles.com/p/articles/mi_m0EIN/is_2007_August_27/ai_n19479875/","source_description":"Food Quality Sensor International Inc. Secures $5.6 Million Financing through European Syndication","raised_amount":5600000,"raised_currency_code":"USD","funded_year":2007,"funded_month":8,"funded_day":27,"company":{"name":"Food Quality Sensor International","permalink":"food-quality-sensor-international","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://www.biolactis.com/en/news/press-release.php?id=3","source_description":"$10 million funding for Biolactis","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":2,"funded_day":7,"company":{"name":"Technologie BiolActis","permalink":"technologie-biolactis","image":{"available_sizes":[[[150,51],"assets/images/resized/0008/4808/84808v1-max-150x150.jpg"],[[197,67],"assets/images/resized/0008/4808/84808v1-max-250x250.jpg"],[[197,67],"assets/images/resized/0008/4808/84808v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.cmptherapeutics.com/assets/PDFs/CMP%20therpeutics%20press%20release%2029-07-10%20%28CDR%29.pdf","source_description":"CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO","raised_amount":1500000,"raised_currency_code":"EUR","funded_year":2010,"funded_month":7,"funded_day":29,"company":{"name":"CMP Therapeutics","permalink":"cmp-therapeutics","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://goliath.ecnext.com/coms2/gi_0199-3632101/BASF-Venture-Capital-invests-in.html","source_description":"BASF Venture Capital invests in novel encapsulation technology.","raised_amount":null,"raised_currency_code":"USD","funded_year":2005,"funded_month":2,"funded_day":3,"company":{"name":"Cavis microcaps","permalink":"cavis-microcaps","image":{"available_sizes":[[[122,57],"assets/images/resized/0009/9650/99650v1-max-150x150.jpg"],[[122,57],"assets/images/resized/0009/9650/99650v1-max-250x250.jpg"],[[122,57],"assets/images/resized/0009/9650/99650v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"","source_description":"Cap Funding Report","raised_amount":1940000,"raised_currency_code":"USD","funded_year":2005,"funded_month":4,"funded_day":13,"company":{"name":"DNage","permalink":"dnage","image":{"available_sizes":[[[150,58],"assets/images/resized/0010/0206/100206v1-max-150x150.jpg"],[[217,84],"assets/images/resized/0010/0206/100206v1-max-250x250.jpg"],[[217,84],"assets/images/resized/0010/0206/100206v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.shieldtherapeutics.com/news.asp?id=9","source_description":"Shield Therapeutics Raises 8.2 million","raised_amount":8200000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":6,"funded_day":1,"company":{"name":"Shield Therapeutics","permalink":"shield-therapeutics","image":{"available_sizes":[[[150,63],"assets/images/resized/0013/7404/137404v1-max-150x150.png"],[[250,105],"assets/images/resized/0013/7404/137404v1-max-250x250.png"],[[261,110],"assets/images/resized/0013/7404/137404v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/09/msi-methylation-sciences-raises-e13-5m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"MSI Methylation Sciences Raises â‚¬13.5M in Series A Financing","raised_amount":13500000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":9,"funded_day":29,"company":{"name":"MSI Methylation Sciences","permalink":"msi-methylation-sciences","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/10/phagenesis-closes-e7m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Phagenesis Closes â‚¬7M Series B Funding Round","raised_amount":7000000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":10,"funded_day":4,"company":{"name":"Phagenesis","permalink":"phagenesis","image":{"available_sizes":[[[150,51],"assets/images/resized/0010/0354/100354v1-max-150x150.png"],[[250,85],"assets/images/resized/0010/0354/100354v1-max-250x250.png"],[[317,108],"assets/images/resized/0010/0354/100354v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/03/phosphate-therapeutics-raises-e10-5m-funding-inventages-venture-capital.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Phosphate Therapeutics Raises up to â‚¬10.5M in Funding from Inventages Venture Capital","raised_amount":10500000,"raised_currency_code":"EUR","funded_year":2012,"funded_month":3,"funded_day":5,"company":{"name":"Phosphate Therapeutics","permalink":"phosphate-therapeutics","image":null}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}